The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico

Journal of Urban Health

Volumn 89, Issue 3, 2012, Pages 519-526

  Reyes, J C ^a,b   Negron J L ^a   Colon H M ^b   Padilla, A M ^a   Millan M Y ^a   Matos, T D ^a,b   Robles, R R ^b  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b Universidad Central del Caribe School of Medicine   (Puerto Rico)

Author keywords

Health consequences; Injectors drug users; Puerto rico; Xylazine

Indexed keywords

COCAINE; DIAMORPHINE; HYPNOTIC SEDATIVE AGENT; XYLAZINE;

ADDICTION; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG COMBINATION; FEMALE; HUMAN; INFORMATION PROCESSING; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PREVALENCE; PUERTO RICO; QUESTIONNAIRE; SKIN ULCER; SUBSTANCE ABUSE;

ADMINISTRATION, INHALATION; ADULT; COCAINE; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; FEMALE; FOCUS GROUPS; HEROIN; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PREVALENCE; PUERTO RICO; QUESTIONNAIRES; SKIN ULCER; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; XYLAZINE; YOUNG ADULT;

EID: 84863779471     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-011-9662-6     Document Type: Article

References (23)

1. Abramovic Z, Sentjurc M, Kristl J, Khan N, Hou H, Swartz HM. Influence of different anesthetics on skin oxygenation studied by electron paramagnetic resonance in vivo. Ski Pharmacol Physiol. 2007;20:77-84. (Pubitemid 46393179)
2. Barroso M, Gallardo E, Margalho C, Devesa N, Pimentel J, Vieira DN. Solid-phase extraction and gas chromatographic-mass spectrometric determination of the veterinary drug xylazine in human blood. J Anal Toxicol. 2007;31:165-169. (Pubitemid 46641588)
3. Capraro AJ, Wiley JF, Tucker J.R. Severe intoxication from xylazine inhalation. Pediatr Emerg Care. 2001;17(6):447-448. (Pubitemid 34049005)
4. Centers for Disease Control and Prevention. Equine Farm Manager dies from Accidental Overdose of Xilazine-Case Report. http://www..cdc.gov/niosh- survapps/statedocs/Doc-Type.aspx?t=CR. Accessed October 13, 2010.
5. Chamberlain PL. Xylazyne. Center for Veterinary Medicine, Food Drug and Administration. http://www.inchem.org/documents/jecfa/jecmono/v38je03.htm. Accessed May 1, 2010.
6. Clatts MC, Welle DL, Goldsamt LA, Lankenau SE. An ethno-epidemiological model for the study of trends in illicit drug use: reflections on the 'emergence' of crack injection. Int J Drug Policy. 2002;13(4):285-296.
7. Colon HM, Perez CM, Melendez M, Marrero E, Ortiz AP, Suárez E. The validity of drug use responses in a household survey in Puerto Rico: comparison of survey responses with urinalysis. Addict Behav. 2010;35(7):667-672.
8. Fisher D, Needle R, Weatherby N, Brown B, Booth R, Williams M. Reliability of drug users self-report (No. PO-C35-3355). Paper presented at
9. Freedenthal S. Racial disparities in mental health service use by adolescents who thought about or attempted suicide. Suicide Life Threat Behav. Feb 2007;37(1):22-34. (Pubitemid 46646505)
10. Freedenthal S. Challenges in assessing intent to die: can suicide attempters be trusted? Omega (Westport). 2007;55(1):57-70.
11. Freedenthal S, Vaughn MG, Jenson JM, Howard MO. Inhalant use and suicidality among incarcerated youth. Drug Alcohol Depend. Sep 6 2007;90(1):81-88. (Pubitemid 46935376)
12. Gallanosa AG, Spyker DA, Shype JR, Morris DL. Human xylazine overdose: a comparative review of clonidine, phenothiazines, and tricyclic antidepressants. Clin Toxicol. 1981;18(6):663-678. (Pubitemid 11017250)
13. Hoffmann U, Meister CM, Golle K, Zschiesche M. Severe intoxication with the veterinary tranquilizer xylazine in humans. J Anal Toxicol. 2001;25(4):245-249. (Pubitemid 32466508)
14. King R, Bird SM, Hay G, Hutchinson SJ. Estimating current injectors in Scotland and their drug-related death rate by sex, region and age-group via Bayesian capture-recapture methods. Stat Methods Med Res. 2009;18(4):341-359.
15. Liu CM, Chiu MJ, Fang CC, Chen WJ. Xylazine Abuse: a rare case of syncope. Clin Toxicol. 2007;45(3):309-311.
16. Muller AA, Osterhoudt KC, Wingert W. Heroin: what's in the mix? Ann Emerg Med. 2007;50(3):352-353. (Pubitemid 47259248)
17. Needle R, Weatherby N, Chitwood D, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9:242-250. (Pubitemid 26019560)
18. Rivera-Vargas D. Elevada la cifra de muertes por sobredosis de drogas. El Nuevo Día. October 27, 2005;Noticias: 26.
19. Robles R, Colón H, Sahai H, Matos T, Marrero C, Reyes J. Behavioral risk factors and human immunodeficiency virus (HIV) prevalence among intravenous drug users in Puerto Rico. Am J Epidemiol. 1992;135:531-540.
20. Rodriguez N, Vargas J, Panelli J, Colon H, Ritchie B, Yamamura Y. GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles. Drug Alcohol Depend. 2008;96(3):290-293.
21. Stillwell ME. A reported case involving impaired driving following self-administration of xylazine. Forensic Sci Int. 2003;134:25-28. (Pubitemid 36802160)
22. Torruella RA. Xylazine (veterinary sedative) use in Puerto Rico. Subst Abuse Treat Prev Policy. 2011;6:7.
23. Wong SC, Curtis JA, Wingert WE. Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. J Forensic Sci. 2008;53(2):495-498. (Pubitemid 351432606)